WVU Cancer Institute debuts treatment for liver metastases

WVU Cancer Institute debuts treatment for liver metastases

A team of surgical oncologists from the WVU Cancer Institute, including Wallis Marsh, MD, Carl Schmidt, MD, and Brian Boone, MD, have performed the state’s first isolated hepatic perfusion, an operation that delivers chemotherapy directly to the liver to treat metastases that cannot be surgically removed.

“Complex surgical procedures like isolated hepatic perfusion are possible here at WVU due to a highly skilled and dedicated team of anesthesiologists, perfusionists, pharmacists, and nurses that maximize the success of the operation,” Dr. Schmidt said.

In many cases, cancer metastases to the liver are unable to be removed because they affect a large area of the organ. By directly infusing chemotherapy into the liver, the patient is able to avoid many of the effects of chemotherapy when it is distributed through the entire system.

“These patients are at an advanced stage of cancer when it has spread to the liver,” Dr. Boone said. “By infusing chemotherapy directly into the liver, we are able to stop or slow the progression of their metastases, giving these patients more time.”

The isolated hepatic perfusion is one of several regional therapy procedures now offered by WVU Medicine surgical oncology, including delivery of heated intraperitoneal chemotherapy (HIPEC) for peritoneal malignancy and placement of hepatic artery infusion pumps for liver metastases.

“The ability to offer advanced procedures like this at WVU Medicine helps us stand apart from other academic medical centers as leaders in innovation,” Dr. Marsh said.

The patient is doing well and is recovering at home.

  • The Bodice Project: Sculptural Exhibit

    The Bodice Project: Sculptural Exhibit

    West Virginia University Health Sciences Center and the Bodice Project invite you to join us February 20 - 22 in the Erickson Alumni Center Nutting Gallery for the Bodice Project Sculptural Exhibit.

    Read More

  • The Bodice Project: Opening Night Reception

    West Virginia University Health Sciences Center and the Bodice Project invite you to join us for an Opening Night Reception at the Erickson Alumni Center on February 19, 2019.*

    Read More

  • Lori Hazlehurst named as WVU Cancer Institute Associate Director

    Lori Hazlehurst named as WVU Cancer Institute Associate Director

    MORGANTOWN, W.Va. – Lori Hazlehurst, Ph.D., Professor (WVU School of Pharmacy - Pharmaceutical Sciences and Co-Leader of the WVU Cancer Institute Research Program the Alexander B. Osborn Hematopoietic Malignancy and Transplantation Program, has been named as the Associate Director for Basic Research at the WVU Cancer Institute.  In this role, she will work closely with Dr. Richard Goldberg, Institute Director, and the leadership team of the WVU Cancer Institute to implement strategic goals to increase the impact of basic and translational cancer research at WVU. The primary strategy is to increase the number of NIH funded investigators focused on cancer research at WVU

    Read More